Carruthers R Michael
Chief Financial Officer | Director
2 companies
Insider Signal Score
48
AverageTrades Analyzed
6
12M Win Rate
40.0%
Avg 3M Return
+0.2%
Avg 12M Return
-38.9%
Carruthers R Michael is a Chief Financial Officer at Edgewise Therapeutics, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 9 sells.
Estimated insider holdings value: $3.3M based on current market prices.
Holdings by Company
Transaction History
Showing 6 filings
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 12, 2025 | EWTX Edgewise Therapeutics, Inc. | Chief Financial Officer | Sale+OE | 1,428 | $13.39 | $19,124.35 | -1.6% | +36.5% | - | |
| May 2, 2025 | EWTX Edgewise Therapeutics, Inc. | Chief Financial Officer | Sale+OE | 1,314 | $16.45 | $21,620.82 | -1.6% | -15.7% | +81.0% | |
| Sep 20, 2024 | EWTX Edgewise Therapeutics, Inc. | Chief Financial Officer | Sale+OE | 125,092 | $28.57 | $3,573,979.93 | -60.5% | +8.9% | -49.6% | |
| May 2, 2024 | EWTX Edgewise Therapeutics, Inc. | Chief Financial Officer | Sale+OE | 2,157 | $18.91 | $40,788.87 | -5.8% | -11.7% | -12.3% | |
| Jan 23, 2024 | EWTX Edgewise Therapeutics, Inc. | Chief Financial Officer | Sale+OE | 90,000 | $15.78 | $1,419,759.00 | -75.6% | -2.5% | +75.5% | |
| May 2, 2023 | EWTX Edgewise Therapeutics, Inc. | Chief Financial Officer | Sale+OE | 1,336 | $8.90 | $11,896.95 | -7.7% | -16.7% | +117.3% |